Methotrexate Orion

Methotrexate, the active ingredient in Methotrexate Orion, is a Antimetabolite (Folate antagonist) presented as a unknown/unknown for Intramuscular, Subcutaneous use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, breast cancer and osteosarcoma in appropriate patients.

GNH USA supplies Methotrexate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexate acts on rapidly dividing cells and inflammatory pathways, making it useful across several disease families. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: improves skin lesions and decreases scaling. - Acute lymphoblastic leukemia: inhibits malignant cell proliferation. - Non‑Hodgkin lymphoma: induces tumor cell death. - Breast cancer: used as part of combination chemotherapy regimens. - Osteosarcoma: contributes to tumor control and disease stabilization.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue or general weakness. - Oral mucosal ulceration (mouth sores). - Mild elevation of liver enzymes.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Profound bone marrow suppression leading to pancytopenia. - Acute kidney injury or renal failure. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Opportunistic infections due to immunosuppression.

Methotrexate requires careful monitoring and specific safety measures. - Liver Function Monitoring: perform baseline and periodic liver enzyme tests. - Hematologic Surveillance: regular complete blood counts to detect myelosuppression. - Pregnancy Contraindication: avoid use in pregnant or planning‑to‑conceive patients (Category X). - Breastfeeding Warning: contraindicated during lactation. - Renal Impairment Caution: dose adjustment or avoidance in severe renal dysfunction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methotrexate interacts with several medicines that can alter its efficacy or safety.

Major Interactions (Avoid): - NSAIDs: increase risk of renal toxicity and myelosuppression. - Penicillins: may enhance bone‑marrow suppression. - Live vaccines: heightened risk of severe infection.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect renal clearance. - Oral contraceptives: reduced effectiveness, consider alternative contraception.